Drugs / 99m-Technetium Ethyl Cysteinate Dimer
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02513992 Background | May 2016 → Jul 2018 | epilepsy | Universitaire Ziekenhuizen KU Leuven | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99m-Technetium Ethyl Cysteinate Dimer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02513992 ↗ |
| Route | Other | “will be injected via an intra-arterial catheter” NCT02513992 ↗ |